Quantcast

Latest emphysema Stories

2010-11-01 07:06:00

IRVINE, Calif., Nov. 1, 2010 /PRNewswire/ -- Uptake Medical Corp., a developer of medical technologies for the nonsurgical treatment of lung diseases including emphysema, announced today that Dr. Steven Kesten will join the company as its vice president and chief medical officer effective November 3, 2010. Dr. Kesten joins Uptake Medical with over 20 years experience in pulmonary medicine including academic research and clinical leadership in the pulmonary industry. He served at...

2010-10-28 15:16:39

A team of researchers from Boston University's Center for Regenerative Medicine and the Pulmonary Center have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases. The findings, which appear in the current issue of Stem Cells, demonstrate the first time lung disease-specific iPSC have been created in a...

2010-10-21 12:49:00

RESEARCH TRIANGLE PARK, N.C., Oct. 21 /PRNewswire/ -- Talecris Biotherapeutics (Nasdaq: TLCR) today announced the publication of results from a study showing that PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) (A1PI) is as effective as PROLASTIN® (Alpha1-Proteinase Inhibitor [Human]) in raising levels of alpha-1 protein in patients with alpha1-antitrypsin (AAT) deficiency. Results of the pharmacokinetic study are published in BMC Clinical...

2010-10-13 18:01:00

LONDON, October 14, 2010 /PRNewswire/ -- - On World Spirometry Day, Doctors Urge Regular "MOT Tests for the Lungs" With new data revealing 23 Europeans die each hour[i] from a preventable lung condition, the European Respiratory Society (ERS) is calling on people across Europe to get their lungs tested on the first ever World Spirometry Day - 14th October. Lung disease is the second biggest killer in Europe, and is rapidly becoming the third biggest cause of death...

2010-10-13 12:15:00

MOUNTAIN VIEW, Calif., Oct. 13 /PRNewswire/ -- PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has received CE Mark approval for its RePneu Lung Volume Reduction Coil (LVRC) System to treat the later stages of emphysema. The RePneu LVRC System is a minimally invasive device intended to improve lung function in emphysema patients by brochoscopically implanting Nitinol...

2010-09-20 12:44:00

BARCELONA, Spain, Sept. 20 /PRNewswire/ -- Talecris Biotherapeutics GmbH announced yesterday the recipients of the 2010 European alpha1-antitrypsin Laurell's Training Awards (eALTA). The annual awards, sponsored by Talecris, provide two fellowships of 50,000 euros to young investigators whose research aims to enhance the understanding and treatment of alpha1-antitrypsin deficiency (AAT deficiency). AAT deficiency is a rare, genetic condition in which low levels of the alpha-1 protein can...

2010-09-08 09:00:00

RIDGEFIELD, Conn., Sept. 8 /PRNewswire/ -- The country's newest health initiative, DRIVE4COPD, announced today that it has added the largest association of respiratory therapists - The American Association for Respiratory Care (AARC) - to its ranks. The AARC joins DRIVE4COPD, the Official Health Initiative of NASCAR®, and fellow partnering organizations the American Lung Association, COPD Foundation and founding sponsor Boehringer Ingelheim Pharmaceuticals, Inc. in a...

2010-09-03 12:30:49

A study published today in the journal Science shows how our bodies try to minimise potential 'collateral damage' caused by our immune system when fighting infection. The research may also provide new clues to why cigarette smoke is a significant risk factor for developing diseases of the lung such as chronic bronchitis and emphysema. When bacteria or viruses enter the body, our immune system fights back to neutralise any danger. One of the key 'soldiers' working for the immune system is a...

2010-08-19 13:52:00

AUSTIN, Texas, Aug. 19 /PRNewswire/ -- What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition. Although such...

2010-07-07 12:31:14

An expensive treatment recommended for a genetic disorder called alpha-1 antitrypsin deficiency has no proven clinical benefit, according to a systematic review by Cochrane Researchers. The disorder causes chronic lung disease and the review concludes that considering the lack of evidence for its benefits, and possible adverse effects, the treatment should not be recommended. Alpha-1 antitrypsin deficiency affects less than one in 1,600 people. Those who inherit the disorder have low levels...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »
Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.